Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.2/5
Arvinas Inc

Arvinas Inc (ARVN US)

4
Analysis
Health CareUnited States
Arvinas, Inc. operates as a bio-pharmaceutical company. The Company develops protein degradation therapeutics for cancers and other diseases. Arvinas serves health care industry worldwide.
more
18 Mar 2025 01:00Issuer-paid

Biopharma Week in Review - March 17, 2025

Trump’s pick for CDC director, former Congressman Dave Weldon, had his nomination withdrawn just hours before the Senate committee hearing.

Logo
222 Views
Share
18 Dec 2024 12:51Issuer-paid

Biopharma Week in Review - December 16, 2024

LLY partnered GLP-1 access with telehealth Ro and presented oral SERD data in breast cancer, rattling HIMS, LFMD, ARVN, and OLMA.

Logo
205 Views
Share
bearishS&P 500 INDEX
22 Apr 2020 00:38

U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely

Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...

Logo
497 Views
Share
bearishS&P 500 INDEX
15 Apr 2020 13:13

U.S. Equity Strategy: Bulls Still In Driver’s Seat, But For How Long?

Continued encouraging COVID-19 news and accommodative moves by the Fed have allowed the bulls to remain in control while short-term support on the...

Logo
444 Views
Share
No more insights
x